TMPRSS2 and prostate carcinoma: Fusion of the TMPRSS2 and ERG (or the related ETV1) genes has been reported to occur in the majority of prostate cancers and is suggested to lead to an androgen‐dependent amplification of ETS‐regulated genes (Tomlins et al., 2005).